Background/Aim: Transition from pediatric to adult care is a challenging turning point. The aim was to evaluate the transition process and needs expressed by patients with chronic endocrine conditions at transition in order to ensure program optimization. Methods: Prospective assessment of the transition period was conducted through completion of standardized questionnaires given to targeted patients. Two types were created: (1) a general questionnaire (GQ) addressing universal aspects of transition, and (2) a specific questionnaire (SQ) exploring concerns related to each endocrine condition. Three endocrinopathies (congenital adrenal hyperplasia, hypogonadotropic hypogonadism and growth hormone deficiency) were selected for assessment since they present specific challenges requiring characterization. Results: Over the last decade, 244 patients in transition were registered in our department and 153 were included since they presented one of the endocrinopathies selected. A total of 73 subjects completed both the GQ and the SQ. Over 80% of the patients were satisfied with the transition process in terms of organization, accessibility and medical care. The actual age of transition corresponded for most to the age considered by patients as ideal for transition. SQs identified psychosexual issues that must be addressed more systematically. Conclusion: This study identified key elements allowing the creation of an improved transition program tailored for our center and for each endocrine condition studied.

Keywords:
Transition, Adolescents, Congenital adrenal hyperplasia, Hypogonadotropic hypogonadism, Growth hormone deficiency
1.
Kennedy A, Sawyer SM: Transition from pediatric to adult services: are we getting it right? Curr Opin Pediatr 2008;20:403–409.
2.
Rapley P, Davidson PM: Enough of the problem: a review of time for health care transition solutions for young adults with a chronic illness. J Clin Nurs 2010;19:313–323.
3.
Betz C, Smith K: Measuring health care transition planning outcomes: challenges and issues. Int J Child Adolesc Health 2011;3:463–472.
4.
Pai AL, Schwartz LA: Introduction to the special section: health care transitions of adolescents and young adults with pediatric chronic conditions. J Pediatr Psychol 2011;36:129–133.
5.
American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians – American Society of Internal Medicine: Consensus statement on health care transitions for young adults with special health care needs. Pediatrics 2002;110:1304–1306.
6.
Kaufman M, Pinzon J and the Adolescent Medicine Committee: Canadian Paediatric Society, position statement. Transition to adult care for youth with special health care needs. Paediatr Child Health 2007;12:785–788.
7.
Algozzine B, Browder D, Karvonen M, Test D, Wood W: Effects of interventions to promote self-determination for individuals with disabilities. Rev Educ Res 2001;71:219–277.
8.
Betz CL: Transition of adolescents with special health care needs: review and analysis of the literature. Issues Compr Pediatr Nurs 2004;27:179–241.
9.
Viner R: Barriers and good practice in transition from paediatric to adult care. J R Soc Med 2001;94:2–4.
10.
Blum R, Garell D, Hodgman CH, Jorissen TW, Okinow NA, Orr DP, Slap GB: Transition from child-centred to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993;14:570–576.
11.
Fleming E, Carter B, Gillibrand W: The transition of adolescents with diabetes from the children’s health care service into the adult health care service: a review of the literature. J Clin Nurs 2002;11:560–567.
12.
Shaw T, DeLaet D: Transition of adolescents to young adulthood for vulnerable populations. Pediatr Rev 2010;31:497–505.
13.
Tucker LB, Cabral DA: Transition of the adolescent patient with rheumatic disease: issues to consider. Pediatr Clin North Am 2005;52:641–652.
14.
King GA, Baldwin PJ, Currie M, Evans J: Planning successful transitions from school to adult roles for youth with disabilities. Child Health Care 2005;34:193–216.
15.
Haydock-White P, Gallay L: Youth with special health care needs and disabilities in transition to adulthood; in Osgood DW, Foster EM, Flanagan C, Ruth GR (eds): On Your Own without a Net: The Transition to Adulthood for Vulnerable Populations. Chicago, University of Chicago Press, 2005, pp 349–374.
16.
Berkowitz S: Transitioning adolescents to adult care: putting theory into practice. Minn Med 2009;92:42–44.
17.
Stewart D: Transition to adult services for young people with disabilities: current evidence to guide future research. Dev Med Child Neurol 2009;51:169–173.
18.
Pugeat M, Nicolino M: From paediatric to adult endocrinology care: the challenge of the transition period. Pediatr Endocrinol Rev 2009;6:519–522.
19.
White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245–291.
20.
Stanhope R: Transition from paediatric to adult endocrinology: hypopituitarism. Growth Horm IGF Res 2004;14:85–88.
21.
Cook DM, Yuen KC, Biller BM, Kemp SF, Vance ML; American Association of Clinical Endocrinologists: American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients – 2009 update. Endocr Pract 2009;15:1–29.
22.
Radovik S, DiVall S: Approach to the growth hormone-deficient child during transition to adulthood. J Clin Endocrinol Metab 2007;92:1195–1200.
23.
Aimaretti G, Corneli G, Rovere S, Croce CG, Ghigo E, Procopio M: Is growth hormone therapy useful to preserve bone mass in transition-phase patients with growth hormone deficiency? J Endocrinol Invest 2005;28:1–5.
24.
Fatio S, Dirlewanger M, Meier CA, Schwitzgebel V: Traitement par hormone de croissance: phase de transition de l’enfance à l’âge adulte. Rev Méd Suisse 2005;6:426–431.
25.
Kruse B, Riepe FG, Krone N, Bosinski HAG, Kloehn S, Partsch CJ, Sippell WG, Mönig H: Congenital adrenal hyperplasia – how to improve the transition from adolescence to adult life. Exp Clin Endocrinol Diabetes 2004;112:343–355.
26.
Arlt W, Willis DS, Wild SH, Krone N, Doherty EJ, Hahner S, Han TS, Carroll PV, Conway GS, Rees DA, Stimson RH, Walker BR, Connell JM, Ross RJ and United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE): Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J Clin Endocrinol Metab 2010;95:5110–5121.
27.
Auchus RJ: Management of the adult with congenital adrenal hyperplasia. Int J Pediatr Endocrinol 2010;2010:614107.
28.
Conway SG: Congenital Adrenal hyperplasia: adolescence and transition. Horm Res 2007;68:155–157.
29.
Speiser PW: Congenital adrenal hyperplasia: transition from childhood to adulthood. J Endocrinol Invest 2001;24:681–691.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.